BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35468845)

  • 41. Content analysis of digital media coverage of the human papillomavirus vaccine school-entry requirement policy in Puerto Rico.
    Colón-López V; Rivera-Figueroa V; Arroyo-Morales GO; Medina-Laabes DT; Soto-Abreu R; Rivera-Encarnación M; Díaz-Miranda OL; Ortiz AP; Wells KB; Vázquez-Otero C; Hull PC
    BMC Public Health; 2021 Jul; 21(1):1286. PubMed ID: 34210308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. School nurses' experiences of delivering the UK HPV vaccination programme in its first year.
    Hilton S; Hunt K; Bedford H; Petticrew M
    BMC Infect Dis; 2011 Aug; 11():226. PubMed ID: 21864404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 'A false sense of security'? Understanding the role of the HPV vaccine on future cervical screening behaviour: a qualitative study of UK parents and girls of vaccination age.
    Henderson L; Clements A; Damery S; Wilkinson C; Austoker J; Wilson S;
    J Med Screen; 2011; 18(1):41-5. PubMed ID: 21536816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis.
    Nadarzynski T; Smith H; Richardson D; Pollard A; Llewellyn C
    Br J Health Psychol; 2017 May; 22(2):345-361. PubMed ID: 28191723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.
    Mesher D; Soldan K; Howell-Jones R; Panwar K; Manyenga P; Jit M; Beddows S; Gill ON
    Vaccine; 2013 Dec; 32(1):26-32. PubMed ID: 24211166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas.
    Kaul S; Do TQN; Hsu E; Schmeler KM; Montealegre JR; Rodriguez AM
    Papillomavirus Res; 2019 Dec; 8():100189. PubMed ID: 31654772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus vaccination in adolescence.
    Russell M; Raheja V; Jaiyesimi R
    Perspect Public Health; 2013 Nov; 133(6):320-4. PubMed ID: 24006173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
    Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 50. Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.
    Gottvall M; Stenhammar C; Grandahl M
    BMJ Open; 2017 Feb; 7(2):e014255. PubMed ID: 28246143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Greek health professionals' perceptions of the HPV vaccine, state policy recommendations and their own role with regards to communication of relevant health information.
    Karamanidou C; Dimopoulos K
    BMC Public Health; 2016 Jun; 16():467. PubMed ID: 27260348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus (HPV) vaccine status and knowledge of students at a university in rural Thailand.
    Chanprasertpinyo W; Rerkswattavorn C
    Heliyon; 2020 Aug; 6(8):e04625. PubMed ID: 32793834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improving skills and institutional capacity to strengthen adolescent immunisation programmes and health systems in African countries through HPV vaccine introduction.
    Dochez C; Burnett RJ; Mbassi SM; Were F; Musyoki A; Trovoada D; Mphahlele MJ
    Papillomavirus Res; 2017 Dec; 4():66-71. PubMed ID: 29179872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women's perceived barriers.
    Gerend MA; Shepherd MA; Lustria ML
    Sex Transm Dis; 2013 May; 40(5):401-5. PubMed ID: 23588130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
    Selvey LA; Roux F; Burns S
    Vaccine; 2020 Mar; 38(14):2971-2977. PubMed ID: 32115296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
    Tung IL; Machalek DA; Garland SM
    PLoS One; 2016; 11(8):e0161846. PubMed ID: 27564213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The school nurse, the school and HPV vaccination: a qualitative study of factors affecting HPV vaccine uptake.
    Brabin L; Stretch R; Roberts SA; Elton P; Baxter D; McCann R
    Vaccine; 2011 Apr; 29(17):3192-6. PubMed ID: 21354481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya.
    Watson-Jones D; Mugo N; Lees S; Mathai M; Vusha S; Ndirangu G; Ross DA
    PLoS One; 2015; 10(6):e0123701. PubMed ID: 26115523
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.